Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: Pooled results from two phase 3 trials (liberty-pn prime and prime2)

被引：0
|
作者：
Yosipovitch, G. [7 ]
Kwatra, S. G. [9 ]
Mollanazar, N. [1 ]
Staender, S. [2 ]
Satoh, T. [3 ]
Laws, E. [4 ]
Mannent, L. P. [5 ]
Mortensen, E. [6 ]
Maloney, J. [6 ]
Shi, G. [4 ]
Bansal, A. [6 ]
Martincova, R. [8 ]
机构：
[1] Univ Penn, Philadelphia, PA USA
[2] Univ Hosp Munster, Munster, Germany
[3] Natl Def Med Coll, Tokorozawa, Saitama, Japan
[4] Sanofi, Bridgewater, NJ USA
[5] Sanofi, Chilly Mazarin, France
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Univ Miami, Miami, FL USA
[8] Sanofi, Prague, Czech Republic
[9] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
650
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 33 条
  • [31] Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials (vol 394, pg 1638, 2019
    Bachert, C.
    Han, J. K.
    Desrosiers, M.
    LANCET, 2019, 394 (10209): : 1618 - 1618
  • [32] IXEKIZUMAB IMPROVES NAIL AND SKIN PSORIASIS THROUGH 52 WEEKS OF TREATMENT IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO RANDOMIZED, DOUBLE-BLIND, PHASE 3, CLINICAL TRIALS (SPIRIT-P1 AND SPIRIT-P2)
    Merola, Joseph F.
    Kishimoto, Mitsumasha
    Adams, David
    Park, So Young
    Thaci, Diamant
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 16 - 16
  • [33] Safety of baricitinib in patients with atopic dermatitis: Results of pooled data from two phase 3 monotherapy randomized, double-blind, placebo-controlled 16-week trials (BREEZE-AD1 and BREEZE-AD2)
    Reich, Kristian
    Lacour, Jean Philippe
    Costanzo, Antonio
    Brinker, Dennis R.
    Rueda, Maria Jose
    Nunes, Fabio P.
    Issa, Maher
    Paller, Amy
    Silverberg, Jonathan I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB28 - AB28
1234